Literature DB >> 3069200

Laboratory aspects of Lyme borreliosis.

A G Barbour1.   

Abstract

Lyme borreliosis (Lyme disease), a common tick-borne disorder of people and domestic animals in North America and Europe, is caused by the spirochete Borrelia burgdorferi. Following the discovery and initial propagation of this agent in 1981 came revelations that other tick-associated infectious disorders are but different forms of Lyme borreliosis. A challenge for the clinician and microbiology laboratory is confirmation that a skin rash, a chronic meningitis, an episode of myocarditis, or an arthritic joint is the consequence of B. burgdorferi infection. The diagnosis of Lyme borreliosis may be established by (i) directly observing the spirochete in host fluid or tissue, (ii) recovering the etiologic spirochete from the patient in culture medium or indirectly through inoculation of laboratory animals, or (iii) carrying out serologic tests with the patient's serum or cerebrospinal fluid. The last method, while lacking in discriminatory power, is the most efficacious diagnostic assay for most laboratories at present.

Entities:  

Mesh:

Year:  1988        PMID: 3069200      PMCID: PMC358062          DOI: 10.1128/CMR.1.4.399

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  167 in total

1.  The fluorescent treponemal antibody absorbed (FTA-ABS) test beading phenomenon in connective tissue diseases.

Authors:  C H McKenna; A L Schroeter; R R Kierland; G G Stilwell; F D Pien
Journal:  Mayo Clin Proc       Date:  1973-08       Impact factor: 7.616

2.  The use of the microhematocrit technic for the recovery of Borrelia duttonii from the blood.

Authors:  J M Goldsmid; K Mahomed
Journal:  Am J Clin Pathol       Date:  1972-08       Impact factor: 2.493

3.  Cultivation of Borrelia hermsi.

Authors:  R Kelly
Journal:  Science       Date:  1971-07-30       Impact factor: 47.728

4.  Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.

Authors:  J A Hardin; L C Walker; A C Steere; T C Trumble; K S Tung; R C Williams; S Ruddy; S E Malawista
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

5.  [Erythema chronicum migrans meningitis - a bacterial infectious disease? (author's transl))].

Authors:  K Weber
Journal:  MMW Munch Med Wochenschr       Date:  1974-11-08

6.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

7.  Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission.

Authors:  A C Steere; J A Hardin; S Ruddy; J G Mummaw; S E Malawista
Journal:  Arthritis Rheum       Date:  1979-05

8.  Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis.

Authors:  A C Steere; A Gibofsky; M E Patarroyo; R J Winchester; J A Hardin; S E Malawista
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

9.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

10.  Susceptibility of the black-legged tick, Ixodes scapularis, to the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  W Burgdorfer; K L Gage
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12
View more
  52 in total

Review 1.  Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable.

Authors:  A Prasad; D Sankar
Journal:  Postgrad Med J       Date:  1999-11       Impact factor: 2.401

2.  Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi.

Authors:  M G Rittig; A Krause; T Häupl; U E Schaible; M Modolell; M D Kramer; E Lütjen-Drecoll; M M Simon; G R Burmester
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

3.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

4.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

6.  Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.

Authors:  R C Johnson; C B Kodner; P J Jurkovich; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

7.  Cross-reactive proteins of Borrelia burgdorferi.

Authors:  H R Bruckbauer; V Preac-Mursic; R Fuchs; B Wilske
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

8.  Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.

Authors:  S Rauer; N Spohn; C Rasiah; U Neubert; A Vogt
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

9.  Lyme Disease: Review from a Canadian perspective.

Authors:  D R Burdge; D O'Hanlon
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

10.  Characterization of a tick isolate of Borrelia burgdorferi that possesses a major low-molecular-weight surface protein.

Authors:  S Kurashige; M Bissett; L Oshiro
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.